摘要
针对目前硬组织替代用钛合金植入体表面生物陶瓷涂层与基体间界面结合差,在受力和疲劳情况下容易剥落,以及生物陶瓷材料性脆易断裂,植入人体后易早期断裂失效等关键问题,开展了低成本、高性能的生物陶瓷涂层材料与生物陶瓷复合材料研究。
本论文通过涂层材料与钛合金基体间的热膨胀系数的匹配设计,优化涂层/基体界面结合,在钛合金基体上沉积六钛酸钾(K2Ti6O13)和K2Ti6O13/HA(羟基磷灰石)生物陶瓷涂层,以获得具有良好生物活性、较高结合强度和耐磨性能的生物活性涂层。首先通过固相反应和化学沉淀法分别制备了K2Ti6O13和HA粉体,确定了粉体的合成工艺,并对其进行了表征;然后用等离子喷涂的方法在Ti-6Al-4V合金基体上分别制备了K2Ti6O13和K2Ti6O13/HA生物陶瓷涂层;利用XRD和SEM技术对材料的相组成和表面与截面形貌进行表征,按照ASTM C-633标准对涂层的结合强度进行了检测,利用摩擦磨损试验机检测了涂层的抗摩擦性能,利用模拟体液培养和傅立叶红外光谱分析了其生物活性。
结果表明,本研究所制的K2Ti6O13具有与Ti-6Al-4V相近的热膨胀系数,通过计算可知K2Ti6O13与HA的重量配比为80%:20%时,K2Ti6O13/HA生物陶瓷涂层的热膨胀系数与Ti-6Al-4V合金一致。通过正交实验获得等离子喷涂的最佳工艺参数:电压39.8V,电流850A,主气45L/min,辅气27.9L/min,距离100mm。在此参数下,Ti-6Al-4V合金基体上K2Ti6O13和K2Ti6O13/HA涂层均具有最大的结合强度,分别为20MPa和23.7MPa。所制备涂层厚度为50~100μm。磨损实验表明涂层可以有效地提高钛合金的耐磨性。通过涂层组织观察现,涂层具有凹凸不平的表面,该表面有利于骨组织的长入。物相分析结果表明,复合涂层中K2Ti6O13与HA有相互助熔的作用,并且两者反应生成了TiO2等新物质。涂层经模拟体液培养后,发现K2Ti6O13/HA涂层表面有钙磷层沉积,具有较好的生物活性。
另外,本研究还采用冷压成型+1050℃、1100℃、1150℃和1200℃无压大气烧结的方法制备了K2Ti6O13生物陶瓷和HA含量分别为25%、50%、75%和100%的K2Ti6O13晶须/HA复合生物陶瓷。然后利用XRD和SEM对材料的相组成和表面与断面形貌进行了表征,检测了其线收缩率、体积密度和气孔率等物理性质,测试了陶瓷的抗弯强度,并通过模拟体液培养试验表征了生物陶瓷的生物活性。试验结果表明,1100℃烧结的K2Ti6O13陶瓷具有最大的的抗弯强度120MPa;复合陶瓷在1150℃和1200℃时烧结致密,HA含量为50%时具有最大的抗弯强度160MPa。单相K2Ti6O13陶瓷烧结后晶须会熔合成粗大而多孔的柱状晶,强度会有所降低,晶相并未发生大的改变。在复合生物陶瓷体系中,HA能促进K2Ti6O13陶瓷发生相变反应,随着HA含量的增加和烧结温度的升高复合陶瓷中的K2Ti6O13逐渐转变为TiO2,部分TiO2会与HA反应生成CaTiO3,或促进其分解生成TCP。1150℃烧结含50%HA的复合陶瓷不仅具有较大的抗弯强度,可达159MPa,而且经模拟体液培养发现,7天就会长出钙磷层,随着培养时间的延长钙磷层会变的厚且致密。同时,1150℃烧结含75%HA的复合陶瓷也具有很好的生物活性,而K2Ti6O13陶瓷的生物活性不太明显。
At present, the researches on the low-cost high-performance bioceramic coatings and bioceramic materials were developed and investigated in order to deal with the peeling of the bio-active coating from the surface of Ti-implant due to poor coating/substrate interfacial bonding, as well as the early in-vivo fracture due to the inherent brittleness of bioceramic materials.
By matching the coefficients of thermal expansion (CTE) between coating material and substrate, the K2Ti6O13 and K2Ti6O13/hydroxyapatite(HA) were designed for the bio-active coatings on Ti-6Al-4V alloy implant with better bio-activity, stronger interfacial bonding, as well as higher wear resistance for bone substitution.
K2Ti6O13 and HA powders were prepared by solid-state sintering and co-precipitation, respectively. The K2Ti6O13 and K2Ti6O13/hydroxyapatite(HA) bio-active coatings were sprayed on Ti-6Al-4V alloy by plasma spraying method. The phasic composition and transformation of the sprayed coating were studied by X-ray diffraction(XRD). The morphologies of the coating surface and interface between the substrate and coating were studied using scanning electron microscopy(SEM). The relationship between the microstructure of coating, mechanical properties and biological properties was studied as well. The coating bonding strength was tested according to ASTM C-633 standard, and the friction performance was examined by the grinding abrasion testing machine. The bioactivity of the sample was studied by cultivating it in simulation body fluid (SBF) and by Fourier Transform Infrared Spectra(FT-IR).
According to the determined CTEs of K2Ti6O13 and Ti-6Al-4V, The two have the similar CTEs, and the CTE of the composite material which comprising of K2Ti6O13 and HA at the weight ratio of 80% : 20% is coincide with that of the Ti-6Al-4V. Utilizing the orthogonal experiment, the spray coating technological parameters were obtained as following: voltage 39.8V, electric current 850A, the main gas 45L/min, auxiliary gas 27.9L/min, as well as spray distance 100mm, under which the maximal bonding strengths of the resulted K2Ti6O13 and K2Ti6O13/HA coatings on Ti-6Al-4V were obtained as 20MPa and 23.7MPa respectively.
The results indicate that the coating and the substrate are bonded well and the thickness of coating is between 50~100μm. The appearance of coating improves the wear-resisting property of Ti-6Al-4V alloy effectively. According to the SEM observations, rough areas can be formed on the coating surface, which is useful for bone cell to grow into. The XRD results indicate that some chemical reaction partially happened between K2Ti6O13 and HA during spraying, producing a mount of TiO2 and CaTiO3 as the reaction products. After being immersed in simulation body fluid (SBF) for 5 days, a few calcium phosphates was deposited on the coating, which indicates that the K2Ti6O13/HA bioceramic coating is of a good bio-activity.
Furthermore, pure K2Ti6O13 bioceramic and K2Ti6O13 whisk reinforced HA composite bioceramic with 0%, 25%, 50%, 75% and 100% HA, were produced by cold-pressing and atmospheric pressureless sintering method at 1050℃, 1100℃, 1150℃and 1200℃, respectively. Detected its surface and interface morphology with SEM, analysed its phase structure with XRD, and analysed its physics performance such as liner shrinkage、density and porosity. Measured the bending strength of the bioceramic, it is revealed that the K2Ti6O13 bioceramic which sintered at 1100℃has the biggest bending strength, and 50% HA content composite ceramic had the biggest bending strength whether sintered at 1150℃or 1200℃. The phasic composition and transformation of the composites were studied by XRD. The morphologies of the sintered bioceramics were observed using SEM. The values of linear shrinkage, volume density and porosity of the sintered specimens were measured too. Finally, the bending strength and biological properties was characterized as well.
The results show that K2Ti6O13 bio-ceramic specimen is of the maximum bending strength 120MPa after sintering at 1100℃, whereas the K2Ti6O13 whisk/HA composite bioceramic became compact after sintering at 1150℃and 1200℃. The bending strength of 50%HA composite bioceramic is obtained as 160MPa, the maximum value of the composites. It is found in pure K2Ti6O13 specimen, K2Ti6O13 whisks melted and agglomerated into coarse porous columnar grains during sintering without phase changes, which results in the decrease of strength. In composites, a chemical reaction partially happened between K2Ti6O13 and HA during sintering, producing with the reaction products of TiO2 and CaTiO3. After 7 days' cultivation in SBF, a calcium phosphate layer appeared on the surface of the K2Ti6O13 whisk/HA composite ceramics, and became thicker and more compact with the extended cultivation period. But the bioactivity of K2Ti6O13 ceramic is not as good as that of the composite bioceramics. It is noticeable the 50%HA composite bioceramic sintered at 1150℃has a good bending strength (159MPa) and a very good bioactivity. And the 75%HA composite bioceramic sintered at 1150℃has a very good bioactivity too.
引文
[1]俞耀庭,张兴栋.生物医用材料[M].天津:天津大学出版社, 2000, 116-135.
[2] Williams D F.材料科学与技术丛书:医用与口腔材料[M].北京:科学出版社, 1999. 25-26.
[3] Williams D F. The Williams Dictionary of Biomaterials[M]. Liverpool, UK: Liverpool University Press, 1999, 40-42.
[4]程逵,翁文剑,葛曼珍.生物陶瓷涂层[M].材料科学与工程, 1998, 16(3): 8-12.
[5]张超武,杨海波.生物材料概论[M].北京:化学工业出版社, 2006, 1-10.
[6] Noort R V. Titanium: the implant material of today[J]. Journal of Material Science, 1987, 22: 3801-3811.
[7] Suchanek W, Yoshimura M. Processing and properties of hydroxyapatite-based biomaterials for use as hard tissue replacement implant[J]. J Master Res., 1998, 13(1): 94-117.
[8] Bonfield W, Best S, Krajewski A, et al. Prospects for Ceramics in Clinical Applications, Proceedings of Fourth EurCeramics[J]. Biomaterial, 1995, 8(3): 3-8.
[9]何宝明.生物医用钛合金材料的开发应用进展、市场状况及问题分析[J].新材料产业, 2003(1): 23-28.
[10] Robert B H. Thermal spraying of biomaterials[J]. Surface and Coatings Technology, 2006, 201(5): 2012-2019.
[11]张亚平,高家诚,王勇.人工关节材料的研究和展望[J].世界科技研究与发展, 2000, 22(1): 47-51.
[12]郑学斌,刘宣勇,丁传贤.人体硬组织替代材料的研究进展[J].物理, 2003, 32(1): 159-164.
[13] Overgaard S. Calcium phosphate coatings for fixation of bone implants[J]. Acta Orthop Scand, 2000, 71: 1-74.
[14]顾汉卿,徐国风,生物医学材料学[M].天津:天津科技翻译出版公司, 1993, 396-397.
[15] Teoh H. Fatigue of biomaterials: A review[J].International Journal of Fatigue, 2000, 22: 825-837.
[16]材料科学技术百科全书编辑委员会.材料科学技术百科全书[M].北京:中国大百科全书出版社, 1995, 924-928.
[17] Chen J, Tong W, Cao Y, et al. Effect of atmosphere on phase transformation in plasma-sprayed hydroxyapatite coatings during heat treatment[J]. J Biomed Mater Res, 1997, 34: 15-22.
[18] Wang K H, Song J, Kang B, et al. Sol-gel derived hydroxyapatite films on alumina substrates[J]. Surface and Coatings Technology, 2000, 123: 252-255.
[19] Klein C P A T, Patka P, et al. Plasma sprayed coating of tetra-calcium phosphate hydroxyapatite, and a-TCP on titanium alloy: an interficial study[J]. J Biomed Mater Res, 1991(25): 53-65.
[20]栗卓新,吴永智,贺定勇,等.微束等离子喷涂氧化锆增韧羟基磷灰石复合涂层[J].焊接学报, 2008, 29(6): 1-4.
[21] Collier J P, Surprenant V A, Mayor M B, et al. Loss of hydroxyapatite coating on retrieved total hip components[J]. J Arthroplasty, 1993, 8: 389-392.
[22] Park J B, Lakes R S. Biomaterials: An introduction[M]. New York: Plenum Press, 1992, 123-125.
[23] Khor K A, Gu Y W, Pan D, et al. Microstructure and mechanical properties of plasma sprayed HA /YSZ/Ti-6Al-4V composite coatings [J]. Biomaterials, 2004, 25 (18): 4009-4017.
[24]阮建明,邹俭鹏,黄伯云.生物材料学[M].北京:科学出版社, 2004: 234-235.
[25] Suchanek W, Yoshimura M. Processing and properties of hydroxyapatite-based biomaterials for use as hard tissue replacement implants[J]. J Mater Res, 1998, 13: 94.
[26] Wang K. The use of titanium for medical application in USA[J]. J Mater Sci and Eng, 1996, A213: 134-137.
[27]王昌祥,郑昌琼,冉均国.关节置换材料及摩擦磨损[J].生物医学工程学杂志, 1997, 14(1): 64-67.
[28] Ichinose S, Muneta T, Sekiya I, et al. The study of metal ion release and cytotoxicity in Co–Cr–Mo and Ti–Al–V alloy in total knee prosthesis-scanning electron microscope observation[J]. J Mater Sci: Mater Med, 2003, 14(1): 79-86.
[29] Achariya R, Yoshiharu M. Electrochemical depositions of calcium phosphate film on commercial pure titanium and Ti–6Al–4V in two types of electrolyte at room temperature Materials[J]. Science and Engineering: C, 2009, 29(1): 275-283.
[30] Heinrich G, Groger T, Rosiwal S M, et al. CVD diamond coated titanium alloy for biomedical and aerospace application[J]. Surface and Coatings Technology, 1997, 94: 514-520.
[31] Pham M T, Rether H, et al. Surface induced reactivity for titanium by ion implantation[J]. J Mater Sci: Mater Med, 2000, 11: 383-391.
[32] Czarnowska E, Wierzchon T, Maranda N A, et al. Improvement of titanium alloy for biomedical application by nitriding and carbonitriding processes under glow discharge conditions[J]. J Mater Sci: Mater Med, 2000, 11: 73-81.
[33] Agarwal A, Balania K, Anderson R, et al. Plasma-sprayed carbon nanotube reinforced hydroxyapatite coatings and their interaction with human osteoblasts in vitro[J]. Biomaterials,2007, 28(4): 618-624.
[34] Ding S J. Properties and immersion behavior of magnetron-sputtered multi-layered hydroxyapatite/titanium composite coatings[J]. Biomaterials, 2003, 24(23): 4233-4238.
[35] Blalock T, Xiao B, Rabiei A. A study on microstructure and properties of calcium phosphate coatings processed using ion beam assisted deposition on heated substrates[J]. Surface and Coatings Technology, 2007, 201(12): 5850-5858.
[36] Krischok S, Blank C, Engel M, et al. Influence of ion implantation on titanium surfaces for medical applications[J]. Surface Science, 2007, 601(18): 3856-3860.
[37] Bharati S, Sinha M K, Basu D. Hydroxyapatite coating by biomimetic method on titanium alloy using concentrated SBF[J].Bulletin of Materials Science, 2005, 28(6): 617-621.
[38] Nie X, Leyland A, Matthews A. Deposition of layered bioceramic hydroxyapatite/TiO2 coatings on titanium alloys using a hybrid technique of micro-arc oxidation and electrophoresis[J]. Surface and Coatings Technology, 2000, 125(1-3): 407-414.
[39] Milella E, Cosentino F, Licciulli A, et al. Preparation and characterisation of titania/hydroxyapatite composite coatings obtained by sol–gel process[J]. Biomaterials, 2001, 22(11): 1425-1431.
[40]高荣发.热喷涂[M].北京:化学工业出版社, 1992, 25-26.
[41]周庆生.等离子喷涂技术[M].南京:江苏科学技术出版社, 1982, 122-125.
[42]徐滨士,朱绍华,刘世参.材料表面工程[M].哈尔滨:哈尔滨工业大学出版社, 2005, 143-150.
[43]杨翅华.等离子喷涂和燃烧火焰喷涂[M].北京:国防工业出版社, 1984, 47-49.
[44]胡传.热喷涂原理及应用[M].北京:中国科学技术出版社, 1994, 39-41.
[45]徐滨士,刘世参.表面工程[M].北京:机械工业出版社, 2001, 92-117.
[46] Baltag L, Watanabe K, Kusakari H, et al. Long-term changes of hydroxyapatite-coated dental implants[J]. J Biomed Mater Res, 2000, 53(1): 76-85.
[47] Kim H, Camata R P, Vohra Y K, et al. Control of phase composition in hydroxyapatite/tetracalcium phosphate biphasic thin coatings for biomedical applications[J]. J Mater Sci: Mater Med, 2005, 16(10): 961-966.
[48] Lu Y P, Li M S, Li S T, et al. Plasma-sprayed hydroxyapatite/titania composite bond coat for hydroxyapatite coating on titanium substrate[J]. Biomaterials, 2004, 25: 4393–4403.
[49]胡传炘,宋幼慧.涂层技术原理及应用[M].北京:化学工业出版社, 2000, 11-12.
[50] Zhang S, Wang Y S, Zeng X T, et al. Evaluation of interfacial shear strength and residual stressof sol-gel derived fluoridated hydroxyapatite coatings on Ti-6Al-4V substrates[J]. Engineering Fracture Mechanics, 2007, 74(12): 1884-1893.
[51] Ning C Y, Wang Y J, Lu W W, et al. Nano-structural bioactive gradient coating fabricated by computer controlled plasma-spraying technology[J]. J Mater Sci: Mater Med, 2006, 17(10): 875-884.
[52] He G, Deng X, Cen Y K, et al. Development and Characterization of nano-TiO2/HA Composite Bioceramic Coating on Titanium Surface[J]. Key Engineering Materials, 2007, 336: 1802-1805.
[53] Yamada K, Imamura K, Itoh H, et al. Bone bonding behavior of the hydroxyapatite containing glass/titanium composite prepared by the Cullet method[J]. Biomaterials, 2001, 22(16): 2207-2214.
[54] Meng X W, Kwon T Y, Yang Y Z, et al. Effects of applied voltages on hydroxyapatite coating of titanium by electrophoretic deposition[J]. J Biomed Mater Part B: Appl. Biomater, 2006, 78(2): 373-377.
[55] Khor K A, Gu Y W, Pan D, et al. Microstructure and mechanical properties of plasma sprayed HA /YSZ/Ti-6Al-4V composite coatings[J]. Biomaterials, 2004, 25 (18): 4009-4017.
[56] Zheng X B, Huang M H, Ding C X, et al. Bond strength of plasma sprayed hydroxyapatite/Ti composite coatings[J]. Biomaterials, 2000, 21 (8): 841-849.
[57]樊丁,李秀坤,郑敏,等. CeO2对激光熔覆生物陶瓷涂层组织形貌的影响[J].兰州理工大学学报, 2007, 33 (6): 14-17.
[58]崔春翔,申玉田,徐艳姬等.钛合金表面原位生成钛酸钾生物陶瓷涂层的制备及其生物相容性[J].稀有金属材料与工程, 2003, 32(8): 627-630.
[59] Tan Y B, Wang X H, Wu Q H, et al. Early peri-implant osteogenesis with functionally graded nanophase hydroxyapatite/bioglass coating on Ti alloys[J]. Key Engineering Materials, 2007, 330-332(1): 553-556.
[60]张亚平,高家诚,文静.钛合金表面激光溶凝一步制备复合生物陶瓷涂层[J].材料研究学报, 1998,12(4): 423-426.
[61] Quek C H, Khor K A, Cheang P, et al. Influence of processing parameters in the plasma spraying of hydroxyaptite/Ti-6Al-4V composite coatings[J]. J Mater Process Technol, 1999, 89-90: 550-555.
[62] Khor K A, Dong J L, Quak C H, et al. Microstructure investigation of plasma sprayed HA/Ti-6Al-4V composites by TEM[J]. Materials Science and Engineering A, 2000, 281(1-2): 221-228.
[63] Piconi C, Maccauro G. Zirconia as a ceramic biomaterial[J]. Biomaterials, 1999, 20(1): 1-25.
[64] Marquis, Peter M. High performance bioceramics[J]. Chemistry in Britain, 1992, 28(3): 245-252.
[65] Ikeda T, Okuda T, Ioku K, et al. The effect of the microstructure ofβ-tricalcium phosphate on the metabolism of subsequently formed bone tissue[J]. Biomaterials, 2007, 28(16): 2612-2621.
[66] Walsh W R, Vizesi F, Michael D, et al.β-TCP bone graft substitutes in a bilateral rabbit tibial defect model[J]. Biomaterials, 2008, 29(3): 266-271.
[67] Hench L L, Splinter R J, Allen W C, et al. Bonding mechanisms at interface of ceramic prosthetic materials[J]. J Biomed Mater Res, 1972, 5(6): 117-141.
[68] Hench L L. Bioactive glasses and glass-ceramics[J]. Materials Science Forum, 1999, 293: 37-64.
[69]陈菲.羟基磷灰石生物医用陶瓷材料的研究与发展[J].中国陶瓷, 2006, 42(4): 8-13.
[70] Silva V V, Lameiras F S, Lobato Z I. Biological reactivity of zirconia-hydroxyapatite composites[J]. J Biomed Mater Res, 2002, 63(5): 583-590.
[71] Kim H W, Lee S Y, Bae C J, et al. Porous ZrO2 bone scaffold coatedwith hydroxyapatite with fluorapatite intermediate layer[J].Biomaterials, 2003, 24(19): 3277-3284.
[72]黄传勇,孙淑珍,张中太.生物陶瓷复合材料的研究[J].中国生物医学工程学报, 2000, 19(3): 281-287.
[73] Ivanchenko L, Fal'kovskaya T. Preparation and properties of hydroxyapatite strengthened with a glass phase[J]. Powder Metallurgy and Metal Ceramics, 2003, 42: 54-59.
[74] Xu J L, Khor K A, Sui J J, et al. Preparation and characterization of a novel hydroxyapatite/carbon nanotubes composite and its interaction with osteoblast-like cells[J]. Materials Science and Engineering C, 2009, 29(3):44-49.
[75] Que W X, Khor K A, Xu J L, et al. Hydroxyapatite/titanianano composites derived by combining high-energy ball milling with spark plasma sintering processes[J]. Journal of the European Ceramic Society, 2008, 28(16): 3083-3090.
[76]徐艳姬. K2Ti6O13晶须的制备、生长机理及微结构研究[D],天津:天津大学, 2005.
[77] Lee M W, Hu X, Li L, et al. Flow behaviour and microstructure evolution innovel SiO2/PP/LCP ternary composites: effects of filler properties and mixing sequence[J]. Polymer International, 2003, 52(2): 276-284.
[78] Bao N Z, Feng X, Lu X H, et al. Study on the formation and growth of potassium titanate wiskers[J]. Journal of Materials Science, 2002, 37: 3035-3043.
[79] Bao N Z, Feng X, Shen L M, et al. Calcination syntheses of a series of potassium titanateand their morphologic evolution[J]. Crystal Growth&Design, 2002, 2(5): 437-442.
[80]俞耀庭,张兴栋,王身国,等.生物应用材料[M] .天津:天津大学出版社, 2000, 128-129.
[81]王娜,王全胜,王富耻.等离子喷涂ZrO2热障涂层工艺参数优化设计[J].中国表面工程, 2004, 3: 15-18.
[82]邹祖讳.复合材料的结构与性能[M].北京:科学出版社, 1999, 214-216.
[83] Pranevicius L. Plasma spray deposition of A1-Al2O3 coatings doped with metal oxides: catalytications[J]. Surface and Coatings Technology, 2000, 123: 122-128.
[84]杨元政,刘正义,庄育智.等离子喷涂Al2O3陶瓷涂层的结构与组织特征[J].兵器材料科学与工程, 2000, 23(3): 7-11.
[85]应保胜,高全杰,但斌斌.等离子喷涂涂层残余应力分析[J].表面技术, 2004, 33(2): 15-17.
[86]郑森林,郑家文.涂层膜基结合强度测定方法研究进展[J].薄膜科学与技术, 1993, 6(2): 85-90.
[87]尹衍生,高振民,张景德,等. Fe3Al/Al2O3陶瓷复合梯度涂层抗热震性能研究[J].硅酸盐学报, 2003, 31(9): 867-871.
[88]戴浩,周融,樊刚.钛板表面生物活性梯度陶瓷涂层的制备[J].江苏冶金, 2006, 34(2): 18-21.
[89]魏斌,费敬银.钛合金生体材料及其表面改性[J].材料导报, 2000, 11(7): 18-21.
[90] Takadama H, Kim H M, Kokubo T, et al. An X-ray photoelectron spectroscopy study of the process of apatite formation on bioactive titanium metal[J]. J Biomed Mater Res, 2001, 55(2): 185-193.
[91]祝桂洪著.陶瓷工艺实验[M].北京:中国建筑出版社, 1996, 46-51.